{"id":"W2035214881","doi":"10.3111/13696998.2014.979938","title":"Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Neoadjuvant therapy; Inflammatory breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004155928,0.001092871,0.001178615,0.001701212,0.001012382,0.001961385,0.002028767,0.0009746068,0.002825452],"category_scores_gemma":[0.01323764,0.0007270274,0.002477387,0.002234849,0.0009440724,0.0006309836,0.001034319,0.0013156,0.0001082096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.100622,"about_ca_system_score_gemma":0.0494932,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9509151,"about_ca_topic_score_gemma":0.9095958,"domain_scores_codex":[0.9972829,0.001168902,0.00008040766,0.0001896087,0.0004978426,0.0007803213],"domain_scores_gemma":[0.9941981,0.00342251,0.0005243761,0.0001320588,0.001190279,0.0005327296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.004366669,0.0005466454,0.04233965,0.0006261228,0.001404117,0.0004556935,0.0001475068,0.9215412,0.0005983169,0.008359242,0.003223311,0.01639146],"study_design_scores_gemma":[0.001197527,0.001136457,0.06506149,0.0001758052,0.001314576,0.0002091653,0.0005165678,0.9232833,0.0005937068,0.003103227,0.003275704,0.000132353],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674584,0.003519513,0.004483263,0.002338854,0.00005097612,0.001238705,0.008675855,0.00008711115,0.0121474],"genre_scores_gemma":[0.9949675,0.0006137897,0.001471474,0.0001548717,0.000007687862,0.000150048,0.001514664,0.000009458181,0.00111058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.100622,"threshold_uncertainty_score":0.7300669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02427292047140693,"score_gpt":0.3442561130701545,"score_spread":0.3199831925987475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}